These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 10409429

  • 1. Prostate cancer expression profiling by cDNA sequencing analysis.
    Huang GM, Ng WL, Farkas J, He L, Liang HA, Gordon D, Yu J, Hood L.
    Genomics; 1999 Jul 15; 59(2):178-86. PubMed ID: 10409429
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of prostatic small-cell neuroendocrine carcinoma.
    Clegg N, Ferguson C, True LD, Arnold H, Moorman A, Quinn JE, Vessella RL, Nelson PS.
    Prostate; 2003 Apr 01; 55(1):55-64. PubMed ID: 12640661
    [Abstract] [Full Text] [Related]

  • 3. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.
    Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumura M, Vedvick TS, Leslie KB, Badaro R, Reed SG.
    Cancer Res; 2000 Mar 15; 60(6):1677-82. PubMed ID: 10749139
    [Abstract] [Full Text] [Related]

  • 4. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
    Ghadersohi A, Sood AK.
    Clin Cancer Res; 2001 Sep 15; 7(9):2731-8. PubMed ID: 11555586
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
    Herness EA, Naz RK.
    Cancer Res; 2003 Jan 15; 63(2):329-36. PubMed ID: 12543784
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.
    Bainbridge MN, Warren RL, Hirst M, Romanuik T, Zeng T, Go A, Delaney A, Griffith M, Hickenbotham M, Magrini V, Mardis ER, Sadar MD, Siddiqui AS, Marra MA, Jones SJ.
    BMC Genomics; 2006 Sep 29; 7():246. PubMed ID: 17010196
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human CD34+ cell EST database: single-pass sequencing of 402 clones from a directional cDNA library.
    Yang Y, Peterson KR, Stamatoyannopoulos G, Papayannopoulou T.
    Exp Hematol; 1996 Apr 29; 24(5):605-12. PubMed ID: 8605965
    [Abstract] [Full Text] [Related]

  • 13. Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium.
    Lin B, White JT, Ferguson C, Wang S, Vessella R, Bumgarner R, True LD, Hood L, Nelson PS.
    Cancer Res; 2001 Feb 15; 61(4):1611-8. PubMed ID: 11245473
    [Abstract] [Full Text] [Related]

  • 14. Relevant genomics of neurotensin receptor in cancer.
    Elek J, Pinzon W, Park KH, Narayanan R.
    Anticancer Res; 2000 Feb 15; 20(1A):53-8. PubMed ID: 10769634
    [Abstract] [Full Text] [Related]

  • 15. Microarray-based expression profiling in prostate tumors.
    Elek J, Park KH, Narayanan R.
    In Vivo; 2000 Feb 15; 14(1):173-82. PubMed ID: 10757075
    [Abstract] [Full Text] [Related]

  • 16. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Chen Q, Watson JT, Marengo SR, Decker KS, Coleman I, Nelson PS, Sikes RA.
    Cancer Lett; 2006 Dec 08; 244(2):274-88. PubMed ID: 16500022
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
    Freedland SJ, Pantuck AJ, Paik SH, Zisman A, Graeber TG, Eisenberg D, McBride WH, Nguyen D, Tso CL, Belldegrun AS.
    Prostate; 2003 Jun 01; 55(4):299-307. PubMed ID: 12712409
    [Abstract] [Full Text] [Related]

  • 18. RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
    Porkka KP, Tammela TL, Vessella RL, Visakorpi T.
    Genes Chromosomes Cancer; 2004 Jan 01; 39(1):1-10. PubMed ID: 14603436
    [Abstract] [Full Text] [Related]

  • 19. Molecular analysis of WFDC1/ps20 gene in prostate cancer.
    Watson JE, Kamkar S, James K, Kowbel D, Andaya A, Paris PL, Simko J, Carroll P, McAlhany S, Rowley D, Collins C.
    Prostate; 2004 Oct 01; 61(2):192-9. PubMed ID: 15305342
    [Abstract] [Full Text] [Related]

  • 20. Identification of a novel prostate cancer-associated tumor antigen.
    Miles AK, Rogers A, Li G, Seth R, Powe D, McArdle SE, McCulloch TA, Bishop MC, Rees RC.
    Prostate; 2007 Feb 15; 67(3):274-87. PubMed ID: 17192878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.